Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2018-01-28
2020-01-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Heart Failure Treatment Pattern Analysis of HF Patients in HF Centers and Non-HF Centers in China
NCT06099028
Heart Failure Patients Registry
NCT04709263
Patient Journey in Hospital With Acute Heart Failure
NCT02621203
The Ibadan Acute and Chronic Heart Failure Project
NCT05936957
Cardiopulmonary Interactions in Patients With Heart Failure
NCT03317314
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Advanced technologies in interventional cardiology, better organization of angiographic laboratories and primary prevention of coronary artery disease as the leading cause of HF, allowed warning its development in CAD patients. But the incidence and prevalence of CHF continue to increase with age as heart failure with preserved ejection fraction predominates in elderly patients. For the moment more than 23 million people over the world suffer from heart failure.
The prevalence of these patients remains very high even in USA - over 5.8 million.However, there is no any database for heart failure patient in Azerbaijan.The purpose of this study is to compose a national database of the etiologies, clinical and demographic characteristics, using diagnostic tests and management of outpatients heart failure in Azerbaijan population.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical diagnosis of heart failure
* NYHA class II-IV heart failure
Exclusion :
* Patients \<18 years old
* Failure to obtain informed consent
* Pregnant or lactating
Previous cardiac transplantation
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prof. Dr. Mehdi Zoghi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. Mehdi Zoghi
President of WHFS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yasmin Rustamova
Baku, , Azerbaijan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.